Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.

NCT06787976 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

140

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV
Insomnia
Anxiety

Interventions

DRUG: Dolutegravir (DTG)
DRUG: Darunavir/Cobicistat (FDC)

Sponsor

Instituto Mexicano del Seguro Social